동성제약

002210KOSPI의약품 제조업

25.0 / 100

Reference Date: 2026-06-10

Financial Score4.5 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure1.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Roughly flat over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Dongseong Pharmaceutical operates 13 facilities across South Korea, with headquarters in Seoul, and is divided into three business segments: pharmaceuticals, hair dyes, and cosmetics. Key products include Jeongrohwan, Seven Eight, and Lances, with pharmaceuticals and hair dyes produced in-house at the Asan plant, while cosmetics are sold through purchased goods.

Number of Employees

307people

Average Salary

42.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.934.0Point

PBR

4.02Industry Average 0.890.0Point

4.5x industry avg (risky)

ROE

-76.44Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

65.78Industry Average 12.430.0Point

5.3x industry avg (risky)

Trend 2023~20250.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼0.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼629.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -32.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 973Won52-week high 1,39052-week low 973

1-month return3.0Point

1m 0% (flat)

Volume trend3.0Point

Volume surge

Detailed Disclosure

14 totalPositive 0Neutral 11Negative 3

Neutral[기재정정]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]2026-06-04
Neutral대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]2026-06-01
Neutral[첨부추가]기업지배구조보고서공시2026-06-01
Neutral기타시장안내 (개선계획 이행 여부 심의 요청)2026-05-22
Neutral기타안내사항(안내공시)2026-05-20